Annual report · 2026 (year to date)

PACVS: state of the evidence 2026

What the Open Source Medicine Foundation research tracker holds on Post-Acute COVID-19 Vaccination Syndrome (PACVS) for 1 January to 21 November 2026: literature flow, registered trials, agents under study, catalogued biomarkers and cohorts. Every figure is computed from the public JSON files linked at the end of this page.

  1. Research Tracker
  2. Annual Reports
  3. PACVS: state of the evidence 2026
Contents:

Summary

14studies dated 2026 in the feed
2registered trials matched
2trials recruiting or active
2trials started in 2026
32biomarkers catalogued
4research cohorts indexed
Read this first. The literature feed is a rolling window of the 14 most recent PubMed results for this condition (currently spanning 27 April 2026 to 24 September 2026), not a complete census of 2026 publications. Monthly counts before the window opens are zero for that reason, not because nothing was published. Only 2 trials match this condition; percentages would be misleading at this size, so counts are shown. Trials for this condition are identified by keyword match on the registry title and condition field, because the tracker's curated condition mapping does not yet cover it. Expect both misses and false positives.

Literature indexed in 2026

The PACVS feed holds 14 PubMed records with a 2026 publication date (14 unique PMIDs) out of 14 records in the feed, drawn from 13 distinct journals. This is a small sample.

Studies indexed per month, 202624JanFebMarApr 2026: 11AprMay 2026: 11MayJun 2026: 44JunJul 2026: 33JulAug 2026: 22AugSep 2026: 33SepOctNovDec
Records by publication month, 2026. Grey month labels are in the future. Months before the feed window opened are zero by construction.

Top journals

Top journals, 2026Scientific reportsScientific reports: 22Diseases (Basel, Switzerland)Diseases (Basel, Switzerland): 11Frontiers in public healthFrontiers in public health: 11CureusCureus: 11Public healthPublic health: 11Pediatrics and neonatologyPediatrics and neonatology: 11World journal of nephrologyWorld journal of nephrology: 11VirusesViruses: 11European journal of translati…European journal of translational myology: 11World journal of transplantat…World journal of transplantation: 11
Journals with the most 2026 records in the feed (top 10; ties broken by first appearance).

Browse the live feed: PACVS research tracker. Weekly changes are in the research digest.

Clinical trials

2 of the 635 ClinicalTrials.gov records in the tracker snapshot (taken 2026-11-21) match PACVS (2 via keyword match). 2 are recruiting, not yet recruiting, enrolling by invitation or active; 2 list a 2026 start date and 2 had their registry record updated in 2026. Median planned or actual enrollment is 130 participants (2 trials report a figure).

By status

Trials by statusNot Yet RecruitingNot Yet Recruiting: 11Enrolling By Invitati…Enrolling By Invitation: 11
Overall status as recorded on ClinicalTrials.gov at snapshot.

By phase

Trials by phasePhase 2Phase 2: 22
"Not applicable" covers behavioural, device, rehabilitation and observational designs.

By sponsor type

Trials by sponsor typeIndustryIndustry: 11Academic / otherAcademic / other: 11
Lead-sponsor class from the registry; "Academic / other" is the registry's OTHER category.

Agents under investigation

Top agents by trial countVyd2311Vyd2311: 11N-Acetylcysteine (NAC)N-Acetylcysteine (NAC): 11Dmso-Based Otic Solut…Dmso-Based Otic Solution With Betahistine, Dexamethasone, And Lidocaine: 11
Interventions named in the most matched trials (top 3 of 3 distinct agents). A trial testing several agents counts once per agent.
AgentTrialsOf which active
Vyd231111
N-Acetylcysteine (NAC)11
Dmso-Based Otic Solution With Betahistine, Dexamethasone, And Lidocaine11

Trials starting in 2026

NCTTrialStatusPhaseStartSponsor
NCT07899346Study of VYD2311 for the Treatment of Adults With Long-COVID or Post-Vaccination Syndrome
Vyd2311
Not Yet RecruitingPhase 22026-10Invivyd, Inc.
NCT07567274DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury
Dmso-Based Otic Solution With Betahistine, Dexamethasone, And Lidocaine, N-Acetylcysteine (NAC)
Enrolling By InvitationPhase 22026-05-15Leading Edge Clinic

All tracked trials: clinical trials tracker.

Therapeutic agents catalogue

The OSMF therapeutic-agents catalogue lists 4 agents with PACVS as a primary condition (of 609 agents overall). Evidence level is the catalogue's own coarse grading, assigned automatically from the number and type of linked studies and trials; it is not a GRADE assessment.

Agents by evidence levelAnecdotalAnecdotal: 33ModerateModerate: 11
Catalogue evidence grading: anecdotal, preliminary or moderate. No agent for any condition is graded higher than moderate.

Browse: therapeutics atlas and agents.

Biomarkers catalogued

The PACVS biomarker atlas (last edited 2026-06-30) holds 32 marker entries across 8 categories, citing 11 distinct DOIs: 16 reported elevated, 11 reduced and 5 with mixed or inconsistent findings. Direction is relative to the comparison group in the cited source (usually healthy controls) and a single entry can rest on one study.

Biomarkers by category and directionAutoimmuneAutoimmune - up: 5Autoimmune - down: 1Autoimmune - mixed: 28FunctionalFunctional - up: 2Functional - down: 68Spike AntigenSpike Antigen - up: 44MolecularMolecular - up: 1Molecular - down: 1Molecular - mixed: 24MetabolicMetabolic - up: 1Metabolic - down: 23SerologicSerologic - up: 1Serologic - down: 12InflammatoryInflammatory - up: 22ProteomicProteomic - mixed: 11
ElevatedReducedMixed / inconsistentNot stated
Marker entries by atlas category, split by reported direction of change.
CategoryElevatedReducedMixedTotal
Autoimmune5128
Functional2608
Spike Antigen4004
Molecular1124
Metabolic1203
Serologic1102
Inflammatory2002
Proteomic0011

Full atlas: PACVS biomarker atlas.

Research cohorts

4 of the 32 cohorts in the OSMF post-acute infection syndrome (PAIS) cohort database relate to PACVS, together enrolling about 1,915 participants where a figure is recorded. This is a curated database, not a systematic census of cohorts.

CohortDesignEnrolledBiobankRegistration
Post-Vac-Syndrom Deutschland patient surveysurvey777not applicable—
VITAE vaccine-injury survey (Halma & Varon)survey706not applicable—
Yale LISTEN post-vaccination syndrome cohort (Krumholz)survey241active—
PACVS registry cohort (Semmler/Mundorf)cross sectional191unknown—

Methods

This page was generated by scripts/build_reports.py on 21 November 2026 from the data snapshot described below. No number is entered by hand.

Limitations

Download the data

All inputs are public JSON files in the research-tracker repository, licensed for reuse with attribution.

Suggested citation

Open Source Medicine Foundation. PACVS: state of the evidence 2026 (year-to-date, generated 21 November 2026). Open Source Medicine Foundation; 2026. https://research.opensourcemed.info/reports/pacvs-state-of-the-evidence-2026.html

For a stable reference, cite the generation date shown; the page is regenerated as data arrive. Weekly updates: subscribe on Substack or follow the digest RSS feed.

Disclaimer. This report is an automated description of a research database maintained by the Open Source Medicine Foundation. It is not a systematic review and not medical advice. Discuss any treatment decision with a qualified clinician.